<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease - Gøtzsche, PC - 2016 | Cochrane Library</title> <meta content="Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease - Gøtzsche, PC - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007851.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease - Gøtzsche, PC - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007851.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007851.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease" name="citation_title"/> <meta content="Peter C Gøtzsche" name="citation_author"/> <meta content="Rigshospitalet" name="citation_author_institution"/> <meta content="pcg@cochrane.dk" name="citation_author_email"/> <meta content="Helle Krogh Johansen" name="citation_author"/> <meta content="Rigshospitalet" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD007851.pub3" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/09/20" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007851.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007851.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007851.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="alpha 1-Antitrypsin [*administration &amp; dosage]; alpha 1-Antitrypsin Deficiency [complications, *drug therapy]; Pulmonary Disease, Chronic Obstructive [*drug therapy, etiology]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007851.pub3&amp;doi=10.1002/14651858.CD007851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="XwNPMGod";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007851\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007851\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007851.pub3",title:"Intravenous alpha\\u20101 antitrypsin augmentation therapy for treating patients with alpha\\u20101 antitrypsin deficiency and lung disease",firstPublishedDate:"Sep 20, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Airways Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XwNPMGod&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007851.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007851.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007851.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007851.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007851.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007851.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007851.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007851.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007851.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007851.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2649 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007851.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/full#CD007851-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/full#CD007851-sec-0073"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/full#CD007851-sec-0015"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/full#CD007851-sec-0020"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/full#CD007851-sec-0021"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/full#CD007851-sec-0044"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/full#CD007851-sec-0067"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/appendices#CD007851-sec-0078"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/table_n/CD007851StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/table_n/CD007851StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/information#CD007851-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Peter C Gøtzsche</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007851.pub3/information#CD007851-cr-0003">Helle Krogh Johansen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/information/en#CD007851-sec-0095">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 20 September 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007851.pub3">https://doi.org/10.1002/14651858.CD007851.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007851-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007851-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007851-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007851-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007851-abs-0001" lang="en"> <section id="CD007851-sec-0001"> <h3 class="title" id="CD007851-sec-0001">Background</h3> <p>Alpha‐1 antitrypsin deficiency is an inherited disorder that can cause chronic obstructive pulmonary disease (COPD). People who smoke are more seriously affected and have a greater risk of dying from the disease. Therefore, the primary treatment is to help people give up smoking. There are now also preparations available that contain alpha‐1 antitrypsin, but it is uncertain what their clinical effect is. </p> </section> <section id="CD007851-sec-0002"> <h3 class="title" id="CD007851-sec-0002">Objectives</h3> <p>To review the benefits and harms of augmentation therapy with intravenous alpha‐1 antitrypsin in patients with alpha‐1 antitrypsin deficiency and lung disease. </p> </section> <section id="CD007851-sec-0003"> <h3 class="title" id="CD007851-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed and <a href="http://www.clinicaltrials.gov" target="_blank">ClinicalTrials.gov</a> to 25 March 2016. </p> </section> <section id="CD007851-sec-0004"> <h3 class="title" id="CD007851-sec-0004">Selection criteria</h3> <p>We included randomised trials of augmentation therapy with alpha‐1 antitrypsin compared with placebo or no treatment. </p> </section> <section id="CD007851-sec-0005"> <h3 class="title" id="CD007851-sec-0005">Data collection and analysis</h3> <p>The two review authors independently selected trials, extracted outcome data and assessed the risk of bias. </p> </section> <section id="CD007851-sec-0006"> <h3 class="title" id="CD007851-sec-0006">Main results</h3> <p>We included three trials (283 participants in the analyses) that ran for two to three years. All participants were ex‐ or never‐smokers and had genetic variants that carried a high risk of developing COPD. Only one trial reported mortality data (one person of 93 died in the treatment group and three of 87 died in the placebo group). There was no information on harms in the oldest trial. Another trial reported serious adverse events in 10 participants in the treatment group and 18 participants in the placebo group. In the most recent trial, serious adverse events occurred in 28 participants in each group. None of the trials reported mean number of lung infections or hospital admissions. In the two trials that reported exacerbations, there were more exacerbations in the treatment group than in the placebo group, but the results of both trials included the possibility of no difference. Quality of life was similar in the two groups. Forced expiratory volume in one second (FEV<sub>1</sub>) deteriorated more in participants in the treatment group than in the placebo group but the confidence interval (CI) included no difference (standardised mean difference ‐0.19, 95% CI ‐0.42 to 0.05; P = 0.12). For carbon monoxide diffusion, the difference was ‐0.11 mmol/minute/kPa (95% CI ‐0.35 to 0.12; P = 0.34). Lung density measured by computer tomography (CT) scan deteriorated significantly less in the treatment group than in the placebo group (mean difference (MD) 0.86 g/L, 95% CI 0.31 to 1.42; P = 0.002). Several secondary outcomes were unreported in the largest and most recent trial whose authors had numerous financial conflicts of interest. </p> </section> <section id="CD007851-sec-0007"> <h3 class="title" id="CD007851-sec-0007">Authors' conclusions</h3> <p>This review update added one new study and 143 new participants, but the conclusions remain unchanged. Due to sparse data, we could not arrive at a conclusion about the impact of augmentation therapy on mortality, exacerbations, lung infections, hospital admission and quality of life, and there was uncertainty about possible harms. Therefore, it is our opinion that augmentation therapy with alpha‐1 antitrypsin cannot be recommended. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007851-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007851-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007851-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007851-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007851-abs-0003">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007851-abs-0002" lang="en"> <h3>Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease </h3> <p><b>Background</b> </p> <p>Alpha‐1 antitrypsin deficiency is an inherited disorder that can cause lung disease (chronic obstructive pulmonary disease or COPD, which is a chronic lung condition that prevents the air supply from getting to the lungs). It affects about 1 in 1600 to 1 in 5000 people. Patients with lung disease suffer from shortness of breath, reduced ability to exercise and wheezing. People who smoke are more seriously affected and have a greater risk of dying from the disease. </p> <p><b>Study characteristics</b> </p> <p>We reviewed the benefits and harms of treating patients who have the form of the disease that affects the lungs with alpha‐1 antitrypsin extracted from blood donations. We found three randomised clinical trials (283 participants in the analyses) comparing treatment with alpha‐1 antitrypsin with placebo (a pretend treatment) for two to three years. All participants were ex‐smokers or had never smoked but had the genetic problem that carried a high risk of developing lung problems. The evidence is current to March 2016. </p> <p><b>Key results</b> </p> <p>Only one trial reported deaths (one of 93 participants died taking the medicine and three of 87 died taking placebo). There was no information on harms in the oldest trial. In another trial, serious adverse events occurred in 10 participants in the medicine group and 18 participants in the placebo group. In the most recent trial, serious adverse events occurred in 28 participants in each group. </p> <p>None of the trials reported on the number of lung infections or hospital admissions. There were more exacerbations (acute worsening in lung function) in the medicine group than in the placebo group, whereas quality of life was similar in the two groups. </p> <p>All trials measured lung function using forced expiratory volume in one second (how much air a person can breathe out during a forced breath) and carbon monoxide diffusion (a medical test that measures how much gas travels from the lungs to the blood). Lung function was slightly worse in participants taking the medicine but the differences were not significant. Lung function deteriorated significantly less when measured by a special type of X‐ray called a computer tomography (CT) scan. Several secondary outcomes were unreported in the largest and most recent trial whose authors had numerous financial conflicts of interest. </p> <p><b>Quality of the evidence</b> </p> <p>Due to a lack of information, we cannot be sure whether this treatment works or not. Therefore, it is our opinion that treatment with alpha‐1 antitrypsin augmentation cannot be recommended. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007851-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007851-sec-0073"></div> <h3 class="title" id="CD007851-sec-0074">Implications for practice</h3> <section id="CD007851-sec-0074"> <p>This review update added one new study and 143 new participants, but the conclusions remained unchanged. Due to sparse data, we could not arrive at a conclusion about the impact of augmentation therapy on mortality, exacerbations, lung infections, hospital admission and quality of life, and there was uncertainty about possible harms. Therefore, it is our opinion that augmentation therapy with alpha‐1 antitrypsin cannot be recommended. </p> </section> <h3 class="title" id="CD007851-sec-0075">Implications for research</h3> <section id="CD007851-sec-0075"> <p>Further studies with surrogate markers cannot be recommended, if the aim is to elucidate whether or not augmentation therapy with alpha‐1 antitrypsin has a relevant clinical effect. Studies should be large enough to detect a possible effect on clinically relevant outcomes including mortality. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007851-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007851-sec-0015"></div> <section id="CD007851-sec-0016"> <h3 class="title" id="CD007851-sec-0016">Description of the condition</h3> <p>Alpha‐1 antitrypsin deficiency is an inherited disorder that can cause lung or liver disease (<a href="./references#CD007851-bbs2-0011" title="Genetics HomeReference . Alpha‐1 antitrypsin deficiency, 2007. ghr.nlm.nih.gov/condition=alpha1antitrypsindeficiency (accessed 16 November 2008). ">Genetics Home Reference 2007</a>). The prevalence of the genotype associated with severe alpha‐1 antitrypsin deficiency is about 1 in 1600 to 1 in 5000 newborns (<a href="./references#CD007851-bbs2-0022" title="O'BrienML , BuistNR , MurpheyWH . Neonatal screening for alpha1‐antitrypsin deficiency. Journal of Pediatrics1978;92(6):1006‐10. ">O'Brien 1978</a>; <a href="./references#CD007851-bbs2-0029" title="SvegerT . Alpha 1‐antitrypsin deficiency in early childhood. Pediatrics1978;62(1):22‐5. ">Sveger 1978</a>). Alpha‐1 antitrypsin helps to regulate protease activity. Proteases are enzymes, and enzymes need to be carefully regulated, otherwise they can attack and damage normal tissues. </p> <p>Cigarette smokers often develop chronic obstructive pulmonary disease (COPD). A major constituent of the lung pathology in people with COPD is pulmonary emphysema, which is characterised by loss of lung tissue and enlarged alveolar spaces. Smokers with hereditary alpha‐1 antitrypsin deficiency have a particularly high risk of developing pulmonary emphysema, for example, almost all smokers with the Z phenotype (PI*ZZ, i.e. who are homozygotic for the deficiency), will develop emphysema in early adult life and their life expectancy is reduced (<a href="./references#CD007851-bbs2-0010" title="EvaldT , DirksenA , KeittelmannS , ViskumK , Kok‐JensenA . Decline in pulmonary function in patients with alpha‐1‐antitrypsin deficiency. Lung1990;168(Suppl):579‐85. ">Evald 1990</a>; <a href="./references#CD007851-bbs2-0018" title="HutchisonDCS . Natural history of alpha1‐protease inhibitor deficiency. American Journal of Medicine1988;84(Suppl 6A):3‐12. ">Hutchison 1988</a>). </p> <p>The major cause of morbidity and death in severe alpha‐1 antitrypsin deficiency is COPD with pulmonary emphysema (<a href="./references#CD007851-bbs2-0019" title="LarssonC . Natural history and life expectancy in severe alpha1‐antitrypsin deficiency, Pi Z. Acta Medica Scandinavica1978;204(5):345‐51. ">Larsson 1978</a>), and liver disease is the second most common complication (<a href="./references#CD007851-bbs2-0025" title="SharpHL . Alpha‐one‐antitrypsin deficiency. Hospital Practice1971;6:83‐96. ">Sharp 1971</a>). The emphysema is mainly located in the lower lobes of the lung, whereas smokers with normal phenotype have predominantly upper lobe disease. </p> <p>The first symptoms of lung disease rarely develop before the age of 30 years in patients with alpha‐1 antitrypsin deficiency, and includes shortness of breath following mild activity, reduced ability to exercise and wheezing (<a href="./references#CD007851-bbs2-0026" title="SilvermanEK , SandhausRA . Alpha1‐antitrypsin deficiency. New England Journal of Medicine2009;360:2749‐57. ">Silverman 2009</a>). About 10% to 15% of people with alpha‐1 antitrypsin deficiency have liver damage. In rare cases, alpha‐1 antitrypsin deficiency also causes a skin condition known as panniculitis, which is characterised by hardened skin with painful lumps or patches (<a href="./references#CD007851-bbs2-0011" title="Genetics HomeReference . Alpha‐1 antitrypsin deficiency, 2007. ghr.nlm.nih.gov/condition=alpha1antitrypsindeficiency (accessed 16 November 2008). ">Genetics Home Reference 2007</a>). </p> </section> <section id="CD007851-sec-0017"> <h3 class="title" id="CD007851-sec-0017">Description of the intervention</h3> <p>Preparations of alpha‐1 antitrypsin are made from normal human plasma from blood donors. The drug is generally infused at a dose of 60 mg/kg intravenously every week and is available in some countries for replacement therapy in patients with symptomatic emphysema although a clinical effect has not been documented in randomised controlled trials (RCTs). </p> </section> <section id="CD007851-sec-0018"> <h3 class="title" id="CD007851-sec-0018">How the intervention might work</h3> <p>The mechanism behind the lung damage is believed to be well understood. Alpha‐1 antitrypsin inhibits protein degrading enzymes and protects the pulmonary tissue against the destructive activity of elastase (<a href="./references#CD007851-bbs2-0026" title="SilvermanEK , SandhausRA . Alpha1‐antitrypsin deficiency. New England Journal of Medicine2009;360:2749‐57. ">Silverman 2009</a>; <a href="./references#CD007851-bbs2-0028" title="SvegerT . Liver disease in alpha1‐antitrypsin deficiency detected by screening of 200,000 infants. New England Journal of Medicine1976;294(24):1316‐21. ">Sveger 1976</a>). Elastase is released by neutrophils when they penetrate into the alveolar wall by chemotaxis induced by cigarette smoke. Therefore, replacement therapy with alpha‐1 antitrypsin might be beneficial. </p> </section> <section id="CD007851-sec-0019"> <h3 class="title" id="CD007851-sec-0019">Why it is important to do this review</h3> <p>It is important to know whether treatment with alpha‐1 antitrypsin is effective for lung disease and might postpone death or lung transplantation. This is an update of a review originally published in 2010 (<a href="./references#CD007851-bbs2-0031" title="GøtzschePC , JohansenHK . Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease. Cochrane Database of Systematic Reviews2010, Issue 7. [DOI: 10.1002/14651858.CD007851.pub2] ">Gøtzsche 2010</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007851-sec-0020" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007851-sec-0020"></div> <p>To review the benefits and harms of augmentation therapy with intravenous alpha‐1 antitrypsin in patients with alpha‐1 antitrypsin deficiency and lung disease. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007851-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007851-sec-0021"></div> <section id="CD007851-sec-0022"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007851-sec-0023"> <h4 class="title">Types of studies</h4> <p>Randomised clinical trials (RCTs) in any language, published or unpublished.</p> </section> <section id="CD007851-sec-0024"> <h4 class="title">Types of participants</h4> <p>Patients with alpha‐1 antitrypsin deficiency, with or without a formal diagnosis of COPD. We did not include trials in newborns, as there is a separate Cochrane review on this (<a href="./references#CD007851-bbs2-0024" title="ShahP , OhlssonA . Alpha‐1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews2001, Issue 3. [DOI: 10.1002/14651858.CD002775] ">Shah 2001</a>). </p> </section> <section id="CD007851-sec-0025"> <h4 class="title">Types of interventions</h4> <p>Experimental intervention: augmentation therapy with alpha‐1 antitrypsin.</p> <p>Control intervention: placebo or no intervention.</p> </section> <section id="CD007851-sec-0026"> <h4 class="title">Types of outcome measures</h4> <section id="CD007851-sec-0027"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD007851-list-0001"> <li> <p>Mortality.</p> </li> <li> <p>Harms of the intervention.</p> </li> </ol> </p> </section> <section id="CD007851-sec-0028"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD007851-list-0002"> <li> <p>Number of exacerbations as defined in the trial report.</p> </li> <li> <p>Number of lung infections.</p> </li> <li> <p>Number of hospital admissions.</p> </li> <li> <p>Quality of life.</p> </li> <li> <p>Carbon monoxide diffusion.</p> </li> <li> <p>Forced expiratory volume in one second (FEV<sub>1</sub>). </p> </li> <li> <p>Lung density measured by computed tomography (CT) scan.</p> </li> </ol> </p> <p>If studies collected data at several time points, we used the data at end of treatment.</p> </section> </section> </section> <section id="CD007851-sec-0029"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007851-sec-0030"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (<a href="./appendices#CD007851-sec-0079">Appendix 1</a>), PubMed (limited to randomised trials, the PubMed clinical queries function) (<a href="./appendices#CD007851-sec-0080">Appendix 2</a>), and <a href="http://www.clinicaltrials.gov" target="_blank">ClinicalTrials.gov</a> (<a href="./appendices#CD007851-sec-0081">Appendix 3</a>), with no restrictions for publication year. Date of last searches was 25 March 2016. </p> </section> <section id="CD007851-sec-0031"> <h4 class="title">Searching other resources</h4> <p>We accepted letters, abstracts and unpublished trials in an attempt to reduce the impact of selective reporting of trials and outcomes. </p> </section> </section> <section id="CD007851-sec-0032"> <h3 class="title" id="CD007851-sec-0032">Data collection and analysis</h3> <p>For each step below, we resolved disagreements by discussion.</p> <section id="CD007851-sec-0033"> <h4 class="title">Selection of studies</h4> <p>Two review authors (PG, HKJ) independently selected the trials to be included in the review. </p> </section> <section id="CD007851-sec-0034"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (PG, HKJ) independently extracted outcome data; one review author (PG) extracted descriptive data, and one review author (HKJ) checked them. </p> </section> <section id="CD007851-sec-0035"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (PG, HKJ) independently assessed the risk of bias. In particular, we recorded generation of the randomisation sequence, concealment of treatment allocation, any blinding and exclusions of participants from the analysis. </p> </section> <section id="CD007851-sec-0036"> <h4 class="title">Measures of treatment effect</h4> <p>We sought data on all randomised participants, that is including participants that the investigators might have excluded because of poor compliance, ineligibility or loss to follow‐up (intention‐to‐treat analysis). </p> <p>For dichotomous data, we used the risk ratio (RR). For continuous outcomes, we preferred end of treatment values when available rather than change from baseline values, as baseline recordings are not always available in clinical trials, and as investigators are inclined to show baseline differences and adjust for them when this procedure favours the experimental treatment (<a href="./references#CD007851-bbs2-0013" title="GøtzschePC . Believability of relative risks and odds ratios in abstracts: cross‐sectional study. BMJ2006;333(7561):231‐4. ">Gøtzsche 2006a</a>). For continuous data and for mean numbers of exacerbations, infections and hospital admissions per participant, we used the mean difference (MD) or standardised mean difference (SMD), as appropriate, but abstained from doing a meta‐analysis if the distribution of the data was non‐Gaussian. For time‐to‐event data, we preferred to use the hazard ratio (HR), but accepted the RR if that was the only statistic available. We present data with 95% confidence intervals (CI). </p> </section> <section id="CD007851-sec-0037"> <h4 class="title">Unit of analysis issues</h4> <p>There were no such issues, as the unit of analysis was the participant in all trials.</p> </section> <section id="CD007851-sec-0038"> <h4 class="title">Dealing with missing data</h4> <p>When trial reports provided insufficient information of potential significance for the results, we contacted the corresponding study author. </p> </section> <section id="CD007851-sec-0039"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity statistically and also used the I<sup>2</sup> statistic (0% to 100%) as a guide to its magnitude (<a href="./references#CD007851-bbs2-0016" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). </p> </section> <section id="CD007851-sec-0040"> <h4 class="title">Assessment of reporting biases</h4> <p>We attempted to assess selective reporting of outcomes within trials, and publication bias related to non‐publication of whole trials. If there are enough trials in future updates of this review (more than 10), we will look for funnel plot asymmetry. </p> </section> <section id="CD007851-sec-0041"> <h4 class="title">Data synthesis</h4> <p>We used a fixed‐effect model for meta‐analysis (which we believe should more appropriately be called a weighted mean, as there is no such thing as a 'fixed‐effect') unless there was heterogeneity (P &lt; 0.10) or other good reasons for using a random‐effects model (e.g. if the interventions were of a very different nature). </p> </section> <section id="CD007851-sec-0042"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We explored the reasons for any heterogeneity (e.g. by comparing the characteristics of participants, interventions and outcomes in the included trials). We planned no subgroup analyses. </p> </section> <section id="CD007851-sec-0043"> <h4 class="title">Sensitivity analysis</h4> <p>If possible, we plan in future to perform a sensitivity analysis where only trials with low risk of bias for allocation concealment and blinding are included (<a href="./references#CD007851-bbs2-0030" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ2008;336(7644):601‐5. ">Wood 2008</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007851-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007851-sec-0044"></div> <section id="CD007851-sec-0045"> <h3 class="title">Description of studies</h3> <section id="CD007851-sec-0046"> <h4 class="title">Results of the search</h4> <p>We retrieved 46 records in CENTRAL and 27 records on PubMed. We identified three placebo‐controlled RCTs that were eligible for the review and found a fourth ongoing trial on <a href="http://www.clinicaltrials.gov" target="_blank">ClinicalTrials.gov</a> that planned to include 339 participants (<a href="./references#CD007851-bbs2-0004" title="Efficacy and safety of alpha1‐proteinase inhibitor (human), modified process (alpha‐1 MP) in subjects with pulmonary emphysema due to alpha1 antitrypsin deficiency (AATD) (SPARTA). clinicaltrials.gov/ct2/show/NCT01983241 (accessed 16 June 2016). ">NCT01983241</a>). </p> </section> <section id="CD007851-sec-0047"> <h4 class="title">Included studies</h4> <p>This review update added one new study and 143 new participants. All three trials included in this review had recruited patients with genetic variants that carried a high risk of developing COPD (<a href="./references#CD007851-bbs2-0026" title="SilvermanEK , SandhausRA . Alpha1‐antitrypsin deficiency. New England Journal of Medicine2009;360:2749‐57. ">Silverman 2009</a>). One study was publicly funded (<a href="./references#CD007851-bbs2-0002" title="DirksenA , DijkmanJH , MadsenF , StoelB , HutchisonDC , UlrikCS , et al. A randomized clinical trial of alpha(1)‐antitrypsin augmentation therapy. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1468‐72. ">Dirksen 1999</a>); the manufacturers of alpha‐1 antitrypsin funded the two other studies. Talecris Biotherapeutics, Inc. financed the EXACTLE trial (EXAcerbations and Computed Tomography scan as Lung End‐points), registered in <a href="http://www.clinicaltrials.gov" target="_blank">ClinicalTrials.gov</a> as NCT00263887, which involved co‐authors from the company (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). CSL Behring financed the RAPID trial (Randomized, placebo‐controlled trial in Alpha‐1 Proteinase Inhibitor Deficiency), registered in <a href="http://www.clinicaltrials.gov" target="_blank">ClinicalTrials.gov</a> as NCT00261833, which involved co‐authors from the company (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>). </p> <p>The trials enrolled 330 ex‐ or never‐smokers who had an FEV<sub>1</sub> of 30% to 80% of the predicted normal value. The participants were treated for at least three years with four‐weekly infusions of alpha‐1 antitrypsin 250 mg/kg (brand name not stated) or albumin 625 mg/kg as placebo (<a href="./references#CD007851-bbs2-0002" title="DirksenA , DijkmanJH , MadsenF , StoelB , HutchisonDC , UlrikCS , et al. A randomized clinical trial of alpha(1)‐antitrypsin augmentation therapy. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1468‐72. ">Dirksen 1999</a>); for two years (with an optional six‐month extension) with weekly infusions of alpha‐1 antitrypsin 60 mg/kg (Prolastin) or 2% albumin as placebo (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>); or for two years (with an optional open‐label treatment with drug for a further two years in some of the included countries) with weekly infusions of alpha‐1 antitrypsin 60 mg/kg (Zemaira) or "a lyophilised placebo" (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>). </p> <p>The primary effect measure was FEV<sub>1</sub> (<a href="./references#CD007851-bbs2-0002" title="DirksenA , DijkmanJH , MadsenF , StoelB , HutchisonDC , UlrikCS , et al. A randomized clinical trial of alpha(1)‐antitrypsin augmentation therapy. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1468‐72. ">Dirksen 1999</a>) or lung density measured by CT scans (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>). The third trial described FEV<sub>1</sub> as the 'gold standard' and lung density as an exploratory outcome (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>), but in a meta‐analysis of Dirksen's two studies (<a href="./references#CD007851-bbs2-0027" title="StockleyRA , ParrDG , PiitulainenE , StolkJ , StoelBC , DirksenA . Therapeutic efficacy of α‐1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respiratory Research2010;11:136. ">Stockley 2010</a>), lung density had changed status, as it was now described as a primary outcome in the second trial. </p> </section> <section id="CD007851-sec-0048"> <h4 class="title">Excluded studies</h4> <p>We excluded no RCTs of alpha‐1 antitrypsin in patients with alpha‐1 antitrypsin deficiency and lung disease that had an untreated control group (see <a href="#CD007851-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD007851-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD007851-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> </section> <section id="CD007851-sec-0049"> <h3 class="title">Risk of bias in included studies</h3> <p>See details in the <a href="./references#CD007851-sec-0101" title="">Characteristics of included studies</a> table. <a href="#CD007851-fig-0002">Figure 2</a> shows a summary of all trials. There were some serious limitations in the trials (e.g. some outcome data were unreported). </p> <div class="figure" id="CD007851-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007851-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD007851-sec-0050"> <h4 class="title">Allocation</h4> <p>The randomisation method in one trial was minimisation (<a href="./references#CD007851-bbs2-0002" title="DirksenA , DijkmanJH , MadsenF , StoelB , HutchisonDC , UlrikCS , et al. A randomized clinical trial of alpha(1)‐antitrypsin augmentation therapy. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1468‐72. ">Dirksen 1999</a>). The procedure was not described, and it was not possible to judge whether it had led to comparable groups, as participant characteristics at baseline were shown for the two included countries and not for the two randomised groups. Another table showed that the groups were comparable at baseline for lung function measurements and CT scan values (<a href="./references#CD007851-bbs2-0002" title="DirksenA , DijkmanJH , MadsenF , StoelB , HutchisonDC , UlrikCS , et al. A randomized clinical trial of alpha(1)‐antitrypsin augmentation therapy. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1468‐72. ">Dirksen 1999</a>). Another trial had adequate sequence generation whereas it was not clear whether there was allocation concealment (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). There were more males in the treatment group than in the placebo group, but this could be a chance finding, as the two groups were comparable for other baseline characteristics (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). The remaining trial randomised participants in blocks of four and did not describe the blinding procedures clearly; thus, it is uncertain whether allocation concealment was adequate (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>). </p> </section> <section id="CD007851-sec-0051"> <h4 class="title">Blinding</h4> <p>The trials were described as double‐blind and placebo controlled, but one trial did not describe the blinding procedure and it was not clear whether the attempted blinding was effective (<a href="./references#CD007851-bbs2-0002" title="DirksenA , DijkmanJH , MadsenF , StoelB , HutchisonDC , UlrikCS , et al. A randomized clinical trial of alpha(1)‐antitrypsin augmentation therapy. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1468‐72. ">Dirksen 1999</a>). It was unclear whether another trial was adequately blinded (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>), whereas the remaining trial was effectively blinded (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). </p> </section> <section id="CD007851-sec-0052"> <h4 class="title">Incomplete outcome data</h4> <p>In one trial, there were no outcome data for two of the 58 participants who dropped out because they resumed smoking, and it was not described to which groups they were randomised (<a href="./references#CD007851-bbs2-0002" title="DirksenA , DijkmanJH , MadsenF , StoelB , HutchisonDC , UlrikCS , et al. A randomized clinical trial of alpha(1)‐antitrypsin augmentation therapy. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1468‐72. ">Dirksen 1999</a>). Another trial described 82 enrolled participants but only 77 were randomised (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). Three of the 77 participants withdrew from the treatment group and seven from the placebo group; data from the CT scans were included from 71 participants, but change from baseline was only available for 67 participants after two years, and for 34 participants after 2.5 years. Therefore, we used CT scan data after two years. In the remaining trial, it was not clear how many participants contributed to the various analyses (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>). One outcome table simply gave the number of randomised participants but a flow chart suggested that data were missing for 10 participants in the treatment group and 20 participants in the placebo group. </p> </section> <section id="CD007851-sec-0053"> <h4 class="title">Selective reporting</h4> <p>We found no signs of selective reporting for the oldest trial (<a href="./references#CD007851-bbs2-0002" title="DirksenA , DijkmanJH , MadsenF , StoelB , HutchisonDC , UlrikCS , et al. A randomized clinical trial of alpha(1)‐antitrypsin augmentation therapy. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1468‐72. ">Dirksen 1999</a>), apart from the fact that the table of baseline values did not give data for the two randomised groups, but from the two countries that were included in the trial. </p> <p>The trial registration for another trial noted that mortality would be recorded, but this was not reported (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). Furthermore, the trial report only addressed CT scan measurements, exacerbations and quality of life (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). For lung function measurements, the report stated that "Values for FEV<sub>1</sub>, DL<sub>CO</sub> [carbon monoxide diffusing capacity] and K<sub>CO</sub> [carbon monoxide transfer coefficient] decreased slightly in both treatment groups during the study but, since these measures were less sensitive than CT, no significant differences were found between the groups (see online supplement for details)". Although this was not selective reporting, we find it curious not to give data on the FEV<sub>1</sub> finding in the main report because FEV<sub>1</sub> was the accepted method (described as the 'gold standard' in the report) (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>), whereas the CT scan measurements were described as 'exploratory', both when the trial was registered and in the trial report. </p> <p>The largest and most recent trial did not report several secondary outcomes (see <a href="./references#CD007851-sec-0101" title="">Characteristics of included studies</a> table) (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>). We wrote to the corresponding author and an author from the company (Zhenling) and asked for these data. We also requested the trial protocol and the clinical study report. We received no reply from these two people but did make contact with the company through its website. The company spokesperson informed us that we should contact the authors. However, we did not get access to the protocol or replies to any of our questions. </p> </section> <section id="CD007851-sec-0054"> <h4 class="title">Other potential sources of bias</h4> <p>There was no information about possible conflicts of interest in the original report of the oldest trial (<a href="./references#CD007851-bbs2-0002" title="DirksenA , DijkmanJH , MadsenF , StoelB , HutchisonDC , UlrikCS , et al. A randomized clinical trial of alpha(1)‐antitrypsin augmentation therapy. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1468‐72. ">Dirksen 1999</a>). In the final version of another trial, the published paper contained a link to "Statement of Interest" (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). However, due to a misprint in the journal, the published link did not work; the statement of interest was available on the European Respiratory Society website (<a href="http://erj.ersjournals.com/misc/statements33.dtl#D" target="_blank">erj.ersjournals.com/misc/statements33.dtl#D</a>). According to other publications, it seems that the first author of both trial reports, Dirksen, may have financial conflicts of interest in relation to companies that produce, sell or research alpha‐1 antitrypsin (<a href="./references#CD007851-bbs2-0005" title="Alpha‐1 Foundation Homepage. www.alphaone.org/ (accessed 9 May 2008). ">Alpha‐1 Foundation 2008</a>; <a href="./references#CD007851-bbs2-0009" title="CLS Behring 2008. www.cslbehring.com/s1/cs/enco/1154398192290/content/1154398189443/content.htm (accessed 9 May 2008). ">CLS Behring 2008</a>; <a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>; <a href="./references#CD007851-bbs2-0023" title="SeersholmN , DirksenA , HansenNCG , HarvingH og Dansk Lungemedicinsk Selskab . Retningslinjer for erstatningsbehandling til patienter med alfa‐1‐antitrypsinmangel, 2007 [Guidelines for replacement therapy in patients with alpha‐1 antitrypsin deficiency]. www.lungemedicin.dk/guidelines/alfa1erstat.pdf (accessed 09 May 2008). ">Seersholm 2007</a>; <a href="./references#CD007851-bbs2-0027" title="StockleyRA , ParrDG , PiitulainenE , StolkJ , StoelBC , DirksenA . Therapeutic efficacy of α‐1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respiratory Research2010;11:136. ">Stockley 2010</a>). Dirksen was listed as a co‐author on the protocol for our Cochrane review but stepped down from that role when he saw the draft for the full review. </p> <p>The acknowledgments in Dirksen's 2009 trial report mentioned that "Editorial assistance was provided by M. Kenig at PAREXEL and was supported by Talecris Biotherapeutics, Inc.". We have reported previously that such descriptions may conceal that the data analysis and the writing of the manuscript was performed by a commercial company, and that, as a result of this, the investigators may not have had much influence on the manuscript (<a href="./references#CD007851-bbs2-0014" title="GøtzschePC , HróbjartssonA , JohansenHK , HaahrMT , AltmanDG , ChanA‐W . Constraints on publication rights in industry‐initiated clinical trials. Journal of the American Medical Association2006;295:1645‐6. ">Gøtzsche 2006b</a>). Another indication of possible commercial influence is the fact that the trade name was preferred over the generic name in the trial report. </p> <p>The most recent trial was also industry supported, and the academic authors had numerous financial conflicts of interest. The sponsor collected the data and three employees of the company participated in data analysis and writing of the report (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>). For this trial, we found remarkably little variation in measures of uncertainty. For example, the width of the CI for annual number of exacerbations was exactly the same for the two groups, 0.38, and the standard deviation for change in patient reported symptoms (St. George's Respiratory Questionnaire (SGRQ) scores) was also exactly the same 16.5 (calculated by us based on the reported standard errors of the mean). This does not necessarily mean that the statistical analyses were biased but it does raise questions about the statistical procedures used or the reporting of the trial. </p> </section> </section> <section id="CD007851-sec-0055"> <h3 class="title" id="CD007851-sec-0055">Effects of interventions</h3> <p>As end‐of‐treatment data were generally not available, we preferably used changes from baseline. We did not detect heterogeneity in any of the analyses (I<sup>2</sup> = 0). </p> <section id="CD007851-sec-0056"> <h4 class="title">Primary outcomes</h4> <section id="CD007851-sec-0057"> <h5 class="title">Mortality</h5> <p>One trial reported mortality data; one patient of 93 in the treatment group and three patients of 87 in the placebo group died (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>). One trial recorded, but did not report, mortality (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). </p> </section> <section id="CD007851-sec-0058"> <h5 class="title">Harms of the intervention</h5> <p>The oldest trial did not report harms (<a href="./references#CD007851-bbs2-0002" title="DirksenA , DijkmanJH , MadsenF , StoelB , HutchisonDC , UlrikCS , et al. A randomized clinical trial of alpha(1)‐antitrypsin augmentation therapy. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1468‐72. ">Dirksen 1999</a>). In another trial, reporting of serious adverse events was inconsistent (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). This trial reported one or more serious adverse events to have occurred in 10 participants in the treatment group and in 18 participants in the placebo group according to the published trial report, but according to the trial register, these numbers were nine in the treatment group versus 15 in the placebo group (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). In the remaining trial, 28 participants in each group experienced serious adverse events (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>). As most of these events were unlikely to have any relation to the treatment, we did not find it worthwhile to meta‐analyse these data. For example, there were cases of malaria, psoriasis and fracture among the nine serious adverse events recorded in one trial in the treatment group (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). </p> </section> </section> <section id="CD007851-sec-0059"> <h4 class="title">Secondary outcomes</h4> <section id="CD007851-sec-0060"> <h5 class="title">Number of exacerbations</h5> <p>The annual exacerbation rate could not be meta‐analysed, as the distribution of the values was highly skewed. In one trial, for example, the mean annual exacerbation rates were 2.55 (SD 2.14) in the treatment group and 2.19 (SD 1.33) in the placebo group (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). In both trials that reported number of exacerbations, there were more exacerbations in the treatment group than in the placebo group, but the results of both trials included the possibility of no difference between groups. In the most recent trial, the numbers were 1.70 (95% CI 1.51 to 1.89) in the treatment group and 1.42 (1.23 to 1.61) in the placebo group; the RR from a negative binomial regression model in which country and treatment were fixed effects and where adjustment was made for treatment duration was 1.26 (95% CI 0.92 to 1.74) (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>). </p> </section> <section id="CD007851-sec-0061"> <h5 class="title">Number of lung infections</h5> <p>We found no data on number of lung infections.</p> </section> <section id="CD007851-sec-0062"> <h5 class="title">Number of hospital admissions</h5> <p>We found no data on number of hospital admissions.</p> </section> <section id="CD007851-sec-0063"> <h5 class="title">Quality of life</h5> <p>Two trials reported quality of life using the SGRQ. One trial reported that SGRQ deteriorated by 1.5 in the treatment group and 2.4 in the placebo group (P = 0.70), which are very small, and clinically irrelevant changes from a mean score at baseline of 44 on a scale that goes up to 100 (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). We abstained from meta‐analysing these data, as they were contradictory in one trial (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>). Data for participant‐reported outcomes were listed on <a href="http://www.clinicaltrials.gov" target="_blank">ClinicalTrials.gov</a> as changes from baseline, which were ‐1.19 in the treatment group and ‐0.09 in the placebo group (<a href="./references#CD007851-bbs2-0001" title="ChapmanKR , BurdonJG , PiitulainenE , SandhausRA , SeersholmN , StocksJM , et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double‐blind, placebo‐controlled trial. Lancet2015;386:360‐8. ChapmanKR , BurdonJGW , PiitulainenE , SandhausRA , SeersholmN , StocksJM . Alpha‐1 antitrypsin (A1AT) preserves lung density In homozygous Alpha‐1 antitrypsin deficiency (A1ATD): a randomized, placebo‐controlled trial. American Journal of Respiratory and Critical Care Medicine2013;187:A6069. NCT00261833 . Zemaira in subjects with emphysema due to alpha1‐proteinase inhibitor deficiency. clinicaltrials.gov/ct2/show/NCT00261833 (accessed 7 August 2015). ">Chapman 2015</a>), but in the published trial report in <i>The Lancet</i>, these changes were listed as ‐1.4 in the treatment group and 2.0 in the placebo group. </p> </section> <section id="CD007851-sec-0064"> <h5 class="title">Forced expiratory volume in one second</h5> <p>On average, FEV<sub>1</sub> deteriorated more in the treatment group than in the placebo group, but there was no significant between‐group difference (SMD ‐0.19, 95% CI ‐0.42 to 0.05; P = 0.12) (<a href="./references#CD007851-fig-0003" title="">Analysis 1.1</a>). </p> </section> <section id="CD007851-sec-0065"> <h5 class="title">Carbon monoxide diffusion</h5> <p>On average, carbon monoxide diffusion deteriorated more in the treatment group than in the placebo group, but there was no significant between‐group difference (SMD ‐0.11, 95% CI ‐0.35 to 0.12; P = 0.34) (<a href="./references#CD007851-fig-0004" title="">Analysis 1.2</a>). </p> </section> <section id="CD007851-sec-0066"> <h5 class="title">Lung density measured by computer tomography scan</h5> <p>One of the trials measured lung density in four different ways in an exploratory manner (<a href="./references#CD007851-bbs2-0003" title="DirksenA , PiitulainenE , ParrDG , DengC , WenckerM , ShakerSB , et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha‐1 antitrypsin deficiency. European Respiratory Journal2009;33(6):1345‐53. [DOI: 10.1183/09031936.00159408] NCT00263887 . Alpha‐1‐antitrypsin (AAT) to treat emphysema in AAT‐deficient patients (EXACTLE) (trial registration). clinicaltrials.gov/ct2/show/NCT00263887?term=antitrypsin&amp;rank=7 (accessed 5 January 2010). ParrDG , DirksenA , PiitulainenE , DengC , WenckerM , StockleyRA . Exploring the optimum approach to the use of CT densitometry in a randomised placebo‐controlled study of augmentation therapy in alpha 1‐antitrypsin deficiency. Respiratory Research2009;10:75. ">Dirksen 2009</a>). Therefore, we used the mean of the four estimates, but it would make virtually no difference if we had chosen any of them, as the results were very similar. When we combined data from all three studies, lung density deteriorated significantly less in the treatment group than in the placebo group, (MD 0.86 g/L, 95% CI 0.31 to 1.42; P = 0.002). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007851-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007851-sec-0067"></div> <section id="CD007851-sec-0068"> <h3 class="title" id="CD007851-sec-0068">Summary of main results</h3> <p>The three trials were small and there were no differences in clinically relevant outcomes. For the surrogates, there was some evidence of a beneficial effect of alpha‐1 antitrypsin. The lung function decline measured as FEV<sub>1</sub> and carbon monoxide diffusion was not slowed down with the drug, but the CT scans of lung density found that treatment might decrease the loss of lung tissue, and this difference was statistically significant. The newest trial was adequately powered for this outcome and also found an effect, but the CI in the meta‐analysis was wide, and in all three trials, the CT scans showed considerable lung density loss, consistent with emphysema progression, in both the treatment and placebo groups. This does not suggest that alpha‐1 antitrypsin augmentation has a major effect on the progression of the disease. </p> <p>In the oldest trial, the drug was not given weekly but every four weeks. This could potentially have affected the results but we saw no such dosing effect in the analyses, and protective levels seem to have been obtained for at least three out of the four weeks (<a href="./references#CD007851-bbs2-0027" title="StockleyRA , ParrDG , PiitulainenE , StolkJ , StoelBC , DirksenA . Therapeutic efficacy of α‐1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respiratory Research2010;11:136. ">Stockley 2010</a>). </p> </section> <section id="CD007851-sec-0069"> <h3 class="title" id="CD007851-sec-0069">Overall completeness and applicability of evidence</h3> <p>The trials did not elucidate the harms well. In clinical use, serious reactions occurred in 1% of the patients in the form of dyspnoea, deterioration of serious heart failure and serious allergic reactions (<a href="./references#CD007851-bbs2-0008" title="ChenS , FarahatiF , MarciniukD , MayersI , BoudreauR , KeatingT . Human α1‐proteinase inhibitor for patients with α1‐antitrypsin deficiency [Technology report no 74]. Ottawa: Canadian Agency for Drugs and Technologies in Health2007. ">Chen 2007</a>). One report on 747 patients mentioned 720 reactions in 174 patients, 72% of which were moderate and 9% were serious (<a href="./references#CD007851-bbs2-0015" title="HeresiGA , StollerJK . Augmentation therapy in a‐1 antitrypsin deficiency. Expert Opinion on Biological Therapy2008;8:515‐26. ">Heresi 2008</a>). </p> </section> <section id="CD007851-sec-0070"> <h3 class="title" id="CD007851-sec-0070">Quality of the evidence</h3> <p>The studies we reviewed were not powered to assess mortality but the crucial question for this very expensive treatment, which can amount up to EUR70,000 annually for each patient (<a href="./references#CD007851-bbs2-0008" title="ChenS , FarahatiF , MarciniukD , MayersI , BoudreauR , KeatingT . Human α1‐proteinase inhibitor for patients with α1‐antitrypsin deficiency [Technology report no 74]. Ottawa: Canadian Agency for Drugs and Technologies in Health2007. ">Chen 2007</a>), or far more, $150,000, in USA (<a href="./references#CD007851-bbs2-0026" title="SilvermanEK , SandhausRA . Alpha1‐antitrypsin deficiency. New England Journal of Medicine2009;360:2749‐57. ">Silverman 2009</a>), is whether it decreases mortality. As only four deaths were reported in the trials, we don't know whether this is the case, and more generally, we had concerns about risk of bias how the included studies were conducted (see <a href="#CD007851-fig-0002">Figure 2</a>). </p> <p>According to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007851-bbs2-0017" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), primary outcomes should be essential for decision‐making and should usually have an emphasis on patient‐important outcomes. This is why we decided that FEV<sub>1</sub> and lung density measured by CT scan should be secondary outcomes in the protocol that we published for our review, in much the same way as one would consider temperature and thorax X‐ray secondary outcomes in a review of an antibiotic for pneumonia. There have been many attempts in healthcare at validating surrogate outcomes and at substituting them for clinically relevant outcomes in trials, but these approaches are unlikely to be successful (<a href="./references#CD007851-bbs2-0012" title="GøtzschePC , LiberatiA , LucaP , TorriV . Beware of surrogate outcome measures. International Journal of Technology Assessment in Health Care1996;12:238‐46. ">Gøtzsche 1996</a>), and diabetes is a good example. Both tolbutamide and rosiglitazone lower blood glucose but they also increase cardiovascular mortality (<a href="./references#CD007851-bbs2-0006" title="ChalmersTC , FrankCS , ReitmanD . Minimizing the three stages of publication bias. JAMA1990;263:1392‐5. ">Chalmers 1990</a>; <a href="./references#CD007851-bbs2-0021" title="NissenSE , WolskiK . Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New England Journal of Medicine2007;356:2457‐71. ">Nissen 2007</a>). </p> </section> <section id="CD007851-sec-0071"> <h3 class="title" id="CD007851-sec-0071">Potential biases in the review process</h3> <p>We are not aware of any potential biases in the review process.</p> </section> <section id="CD007851-sec-0072"> <h3 class="title" id="CD007851-sec-0072">Agreements and disagreements with other studies or reviews</h3> <p>One Canadian health technology assessment report concluded that there was no evidence showing health improvement in patients receiving augmentation therapy with alpha‐1 antitrypsin (<a href="./references#CD007851-bbs2-0008" title="ChenS , FarahatiF , MarciniukD , MayersI , BoudreauR , KeatingT . Human α1‐proteinase inhibitor for patients with α1‐antitrypsin deficiency [Technology report no 74]. Ottawa: Canadian Agency for Drugs and Technologies in Health2007. ">Chen 2007</a>). This report reviewed only results from the oldest trial (<a href="./references#CD007851-bbs2-0002" title="DirksenA , DijkmanJH , MadsenF , StoelB , HutchisonDC , UlrikCS , et al. A randomized clinical trial of alpha(1)‐antitrypsin augmentation therapy. American Journal of Respiratory and Critical Care Medicine1999;160(5 Pt 1):1468‐72. ">Dirksen 1999</a>). One 2009 meta‐analysis found a positive effect of alpha‐1 antitrypsin on FEV<sub>1</sub> but it was unreliable, as it included historically controlled before‐and‐after studies (<a href="./references#CD007851-bbs2-0007" title="ChapmanKR , StockleyRA , DawkinsC , WilkesMM , NavickisRJ . Augmentation therapy for alfa‐1 antitrypsin deficiency: a meta‐analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease2009;6(3):177‐84. ">Chapman 2009</a>). An individual patient data meta‐analysis of the first two trials was published in 2010 (<a href="./references#CD007851-bbs2-0027" title="StockleyRA , ParrDG , PiitulainenE , StolkJ , StoelBC , DirksenA . Therapeutic efficacy of α‐1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respiratory Research2010;11:136. ">Stockley 2010</a>). Talecris Biotherapeutics, Inc. sponsored the meta‐analysis and "technical editorial assistance was provided". It reported on surrogate outcomes only, and we preferred to use the original published trial data for our meta‐analyses. </p> <p>The authors of a 2009 review had substantial conflicts of interest related to companies selling alpha‐1 antitrypsin (<a href="./references#CD007851-bbs2-0026" title="SilvermanEK , SandhausRA . Alpha1‐antitrypsin deficiency. New England Journal of Medicine2009;360:2749‐57. ">Silverman 2009</a>). They advised that augmentation therapy should be considered in patients with alpha‐1 antitrypsin deficiency "although compelling evidence of benefit is lacking from randomized trials". They furthermore noted that the guidelines of the American Thoracic Society and the European Respiratory Society recommend augmentation therapy for patients with airflow obstruction related to alpha‐1 antitrypsin deficiency. In 2012, a clinical practice guideline appeared from the Canadian Thoracic Society (<a href="./references#CD007851-bbs2-0020" title="MarciniukDD , HernandezP , BalterM , BourbeauJ , ChapmanKR , FordGT , et al. Alpha‐1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline. Canadian Respiratory Journal2012;19:109‐16. ">Marciniuk 2012</a>). The authors of this guideline had numerous financial conflicts of interest in relation to manufacturers of the drug and their literature review for the guideline did not adhere to common standards for systematic reviews (e.g. there were no search strategies). The authors also included observational studies. Their recommendation was, "We suggest A1AT [alpha‐1 antitrypsin] augmentation therapy may be considered in nonsmoking or exsmoking patients with COPD (FEV<sub>1</sub> 25% to 80% predicted) attributable to emphysema and documented A1AT (level ≤11 μmol/L), who are receiving optimal pharmacological and nonpharmacological therapies (including comprehensive case management and pulmonary rehabilitation) because of benefits in CT scan lung density (Grade of recommendation: 2B) and mortality (Grade of recommendation: 2C)". </p> <p>In our opinion, these recommendations are not supported by the evidence presented in this review. The drug has not shown any clinical benefit, it has important adverse effects and it is extremely costly. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007851-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/urn:x-wiley:14651858:media:CD007851:CD007851-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_t/tCD007851-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD007851-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/full#CD007851-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007851-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/urn:x-wiley:14651858:media:CD007851:CD007851-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_t/tCD007851-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007851-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/full#CD007851-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007851-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/urn:x-wiley:14651858:media:CD007851:CD007851-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_t/tCD007851-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐1 antitrypsin versus placebo, Outcome 1 Forced expiratory volume in 1 second (FEV1), change (mL or %)." data-id="CD007851-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐1 antitrypsin versus placebo, Outcome 1 Forced expiratory volume in 1 second (FEV<sub>1</sub>), change (mL or %). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/references#CD007851-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007851-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/urn:x-wiley:14651858:media:CD007851:CD007851-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_t/tCD007851-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐1 antitrypsin versus placebo, Outcome 2 Carbon monoxide diffusion, change (mmol/minute/kPa or %)." data-id="CD007851-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐1 antitrypsin versus placebo, Outcome 2 Carbon monoxide diffusion, change (mmol/minute/kPa or %). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/references#CD007851-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007851-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/urn:x-wiley:14651858:media:CD007851:CD007851-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_t/tCD007851-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Alpha‐1 antitrypsin versus placebo, Outcome 3 Computer tomography (CT) lung density, change (g/L)." data-id="CD007851-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Alpha‐1 antitrypsin versus placebo, Outcome 3 Computer tomography (CT) lung density, change (g/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/references#CD007851-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/media/CDSR/CD007851/image_n/nCD007851-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD007851-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Alpha‐1 antitrypsin versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Forced expiratory volume in 1 second (FEV<sub>1</sub>), change (mL or %) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>283</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.42, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Carbon monoxide diffusion, change (mmol/minute/kPa or %) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>283</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.35, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Computer tomography (CT) lung density, change (g/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>273</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.31, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Alpha‐1 antitrypsin versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007851.pub3/references#CD007851-tbl-0001">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007851.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007851-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007851-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="ru#CD007851-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007851\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007851\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007851\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007851\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007851\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XwNPMGod&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007851.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007851.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007851.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007851.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007851.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714029397"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007851.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714029401"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007851.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d64b40bde937a',t:'MTc0MDcxNDAyOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 